Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1988-04-29
1990-05-15
Lipovsky, Joseph A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514178, 552526, 552632, 552636, 552615, 540114, A61K 3156, C07J 100
Patent
active
049258346
ABSTRACT:
A 3-methylene-4-androsten-17-one of formula I ##STR1## wherein R.sub.a represents a hydrogen atom or a saturated or unsaturated straight-chain or branched-chain, optionally substituted alkyl radical with 1-6 carbon atoms, in which R.sub.a is in the alpha- or beta-position, and
REFERENCES:
patent: 3239419 (1966-03-01), Bruckner et al.
patent: 3301880 (1967-01-01), van Vliet et al.
patent: 3450720 (1969-06-01), La Lancette
patent: 4289762 (1981-09-01), Metcalf et al.
patent: 4473564 (1984-09-01), de Winter
patent: 4546098 (1985-10-01), Fishman et al.
Brodie, A. M., et al., "Studies on the Mechanism of Estrogen Biosynthesis in the Rat Ovary," J. Steroid Biochem., 1976, vol. 7, pp. 787-791.
Chemical Abstracts, vol. 105, Nr. 9, 1, Sep. 1, 1986.
Bohlmann Rolf
Henderson David
Laurent Henry
Nishino Yukishige
Lipovsky Joseph A.
Schering Aktiengesellschaft
LandOfFree
3-methylene-4-androsten-17-ones, process for their production an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-methylene-4-androsten-17-ones, process for their production an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-methylene-4-androsten-17-ones, process for their production an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-621628